WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build
WHO Antenatal Care Guideline Implementation Guide
0.3.0 - CI Build
WHO Antenatal Care Guideline Implementation Guide, published by World Health Organization (WHO). This guide is not an authorized publication; it is the continuous build for version 0.3.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-anc/ and changes regularly. See the Directory of published versions
| Active as of 2021-06-11 |
{
"resourceType" : "PlanDefinition",
"id" : "ANCDT09",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <table class=\"grid dict\">\n \n <tr>\n <th scope=\"row\"><b>Id: </b></th>\n <td style=\"padding-left: 4px;\">ANCDT09</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Url: </b></th>\n <td style=\"padding-left: 4px;\"><a href=\"PlanDefinition-ANCDT09.html\">ANC.DT.09 Heptatitis B testing</a></td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Version: </b></th>\n <td style=\"padding-left: 4px;\">0.3.0</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Identifier: </b></th>\n <td style=\"padding-left: 4px;\">\n \n \n <p style=\"margin-bottom: 5px;\">\n <b>value: </b> <span>ANC.DT.09</span>\n </p>\n \n </td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Name: </b></th>\n <td style=\"padding-left: 4px;\">ANCDT09</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Title: </b></th>\n <td style=\"padding-left: 4px;\">ANC.DT.09 Heptatitis B testing</td>\n </tr>\n \n \n \n <tr>\n <th scope=\"row\"><b>Status: </b></th>\n <td style=\"padding-left: 4px;\">active</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Experimental: </b></th>\n <td style=\"padding-left: 4px;\">false</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Type: </b></th>\n <td style=\"padding-left: 4px;\">\n \n \n \n <p style=\"margin-bottom: 5px;\">\n <b>system: </b> <span><a href=\"http://hl7.org/fhir/R4/codesystem-plan-definition-type.html\">http://terminology.hl7.org/CodeSystem/plan-definition-type</a></span>\n </p>\n \n \n <p style=\"margin-bottom: 5px;\">\n <b>code: </b> <span>eca-rule</span>\n </p>\n \n \n \n \n \n </td>\n </tr>\n \n \n \n <tr>\n <th scope=\"row\"><b>Date: </b></th>\n <td style=\"padding-left: 4px;\">2021-06-11 23:02:59-0600</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Publisher: </b></th>\n <td style=\"padding-left: 4px;\">World Health Organization (WHO)</td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Description: </b></th>\n <td style=\"padding-left: 4px;\">Depending on the population prevalence, and woman's medical history, conduct hepatitis B testing</td>\n </tr>\n \n \n \n \n <tr>\n <th scope=\"row\"><b>Use Context: </b></th>\n <td style=\"padding-left: 4px;\">\n <table class=\"grid-dict\">\n <tr><th><b>code</b></th><th><b>value</b></th><th><b>display</b></th></tr>\n \n <tr>\n <td>task</td>\n <td>ANC.B9.</td>\n <td>Conduct laboratory tests and imaging</td>\n </tr>\n \n </table>\n </td>\n </tr>\n \n \n <tr>\n <th scope=\"row\"><b>Jurisdiction: </b></th>\n <td style=\"padding-left: 4px;\">001</td>\n </tr>\n \n \n \n \n \n \n \n \n\n \n <tr>\n <th scope=\"row\"><b>Libraries: </b></th>\n <td style=\"padding-left: 4px;\">\n <table class=\"grid-dict\">\n \n <tr><td><a href=\"Library-ANCDT09.html\">ANC.DT.09 Heptatitis B testing</a></td></tr>\n \n </table>\n </td>\n </tr>\n \n\n \n <tr>\n <th scope=\"row\"><b>Actions: </b></th>\n <td style=\"padding-left: 4px;\">\n <table class=\"grid-dict\">\n \n <tr>\n <td>\n <b> ANC.DT.09 Heptatitis B testing:</b> <br/>\n <b>When:</b> <i>Named Event:</i> ANC.B9. Conduct laboratory tests and imaging<br/>\n \n \n <b>Then:</b>\n <table class=\"grid-dict\">\n \n <tr>\n <td>\n Hepatitis B testing is recommended for at-risk women.\nHBsAg laboratory-based immunoassay is the preferred method for testing for Hep B infection in pregnancy; if immunoassay is not available, HBsAg rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) HBsAg testing.<br/>\n \n <b>If:</b> <i>Applicability:</i> (((&quot;Population prevalence of hepatitis B&quot; ≥ 2%)\n OR (&quot;HIV status&quot; = &quot;HIV positive&quot;))\n OR (Current alcohol and/or other substance use&quot; = &quot;Injectable drugs&quot;))\n OR (&quot;Occupation&quot; = &quot;Employment that puts woman at increased risk for HIV (e.g. sex worker)&quot;) <i>(Should Conduct hepatitis B test)</i><br/>\n \n \n \n </td>\n </tr>\n \n </table>\n \n </td>\n </tr>\n \n </table>\n </td>\n </tr>\n \n </table>\n</div>"
},
"url" : "http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT09",
"identifier" : [
{
"use" : "official",
"value" : "ANC.DT.09"
}
],
"version" : "0.3.0",
"name" : "ANCDT09",
"title" : "ANC.DT.09 Heptatitis B testing",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
"code" : "eca-rule"
}
]
},
"status" : "active",
"experimental" : false,
"date" : "2021-06-11T23:02:59-06:00",
"publisher" : "World Health Organization (WHO)",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "https://www.who.int"
}
]
}
],
"description" : "Depending on the population prevalence, and woman's medical history, conduct hepatitis B testing",
"useContext" : [
{
"code" : {
"system" : "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code" : "task",
"display" : "Workflow Task"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://fhir.org/guides/who/anc-cds/CodeSystem/activity-codes",
"code" : "ANC.B9.",
"display" : "Conduct laboratory tests and imaging"
}
]
}
}
],
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001"
}
]
}
],
"library" : [
🔗 "http://fhir.org/guides/who/anc-cds/Library/ANCDT09"
],
"action" : [
{
"title" : "ANC.DT.09 Heptatitis B testing",
"trigger" : [
{
"type" : "named-event",
"name" : "ANC.B9. Conduct laboratory tests and imaging"
}
],
"action" : [
{
"id" : "1",
"title" : "Conduct hepatitis B test",
"description" : "Conduct hepatitis B test",
"textEquivalent" : "Hepatitis B testing is recommended for at-risk women.\nHBsAg laboratory-based immunoassay is the preferred method for testing for Hep B infection in pregnancy; if immunoassay is not available, HBsAg rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) HBsAg testing.",
"documentation" : [
{
"type" : "citation",
"label" : "Guidelines on hepatitis B and C testing (2017): Recommendation 2 (4)"
}
],
"condition" : [
{
"kind" : "applicability",
"expression" : {
"description" : "(((\"Population prevalence of hepatitis B\" ≥ 2%)\n OR (\"HIV status\" = \"HIV positive\"))\n OR (Current alcohol and/or other substance use\" = \"Injectable drugs\"))\n OR (\"Occupation\" = \"Employment that puts woman at increased risk for HIV (e.g. sex worker)\")",
"language" : "text/cql-identifier",
"expression" : "Should Conduct hepatitis B test"
}
}
]
}
]
}
]
}